Industry

Innovative clinical trial targets Parkinson’s disease through intestinal microbiome study

The study seeks to identify specific microbial and metabolic markers in the small intestinal fluid and blood of PD patients, offering new avenues for therapeutic intervention.

AI and the Microbiome: Crafting the Future of Health with Evogene and Verb Biotics

Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.

Novonesis: a new dawn for global biosolutions

Novozymes and Chr. Hansen have successfully merged to form Novonesis, heralding a new chapter in sustainable business practices and environmental stewardship.

QIAGEN and Penn State forge pioneering alliance to advance microbiome sciences

Underpinning this partnership is a shared vision championed by both entities, emphasizing the interconnectedness of human, animal, and ecosystem health—a concept central to the 'One Health' approach.

Explore the latest update from SynBalance on the gut-skin axis

Join SynBalance, platinum sponsor at Probiota Global 2024 (7-9 February, Milan), and discover the newst scientific data on ProBeautyShield, the probiotic ingredient designed for skin health.

Locus Biosciences Receives $23.9 Million Boost for Bacteriophage Therapy Advancement in UTI Treatment

Their work in engineering bacteriophages to target pathogenic bacteria represents a significant leap in treating bacterial and inflammatory diseases.

Biocodex and My Health forge strategic alliance to revolutionize microbiota market

The partnership centers around the marketing of DUOSPORE®, a dietary supplement developed by My Health.

MetaPath project unites public and private sectors to drive innovation in microbial consortia

The MetaPath project has reached a pivotal juncture, marking a significant milestone in its journey.

Innovative Study Highlights the Power of Prebiotics in Enhancing Gastrointestinal and Sleep Health

Clasado Biosciences and PCSG Unveil Real World Evidence of Bimuno® GOS's Benefits.

A nutraceutical from Biofarma Group to support the treatment of bacterial prostatitis

The Research and Development laboratories of Biofarma Group have developed a nutraceutical with multilayer technology to target prostatitis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top